The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Mease, P. J., Goffe, B. S., Metz, J., VanderStoep, A., Finck, B., & Burge, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02530-7 · Cited by 1,446
Self-citationEtanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
Mease, P. J., Kivitz, A. J., Burch, F. X., Siegel, E. L., Cohen, S. B., Ory, P., Salonen, D., Rubenstein, J., Sharp, J. T., & Tsuji, W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20335 · Cited by 882
Self-citationPsoriatic Arthritis (PSA) - An Analysis of 220 Patients
(1987) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068085 · Cited by 639
Clegg, D. O., Reda, D. J., Mejias, E., Cannon, G. W., Weisman, M. H., Taylor, T., Budiman‐Mak, E., Blackburn, W. D., Vasey, F. B., Mahowald, M. L., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391210 · Cited by 447
Self-citationKaltwasser, J. P., Nash, P., Gladman, D., Rosen, C. F., Behrens, F., Jones, P., Wollenhaupt, J., Falk, F. G., & Mease, P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20253 · Cited by 413
Self-citationThe epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991.
Shbeeb, M. I., Uramoto, K. M., Gibson, L. E., O’Fallon, W. M., & Gabriel, S. E. (2000) · PubMed · Cited by 392
Husted, J. A., Gladman, D. D., Farewell, V. T., & Cook, R. J. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200104)45:2<151::aid-anr168>3.0.co;2-t · Cited by 347
Self-citationWong, K., Gladman, D. D., Husted, J., Long, J. A., Farewell, V. T., & Long, J. A. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401021 · Cited by 339
Self-citationGladman, D. D., Farewell, V. T., Wong, K., & Husted, J. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199806)41:6<1103::aid-art18>3.0.co;2-n · Cited by 314
Self-citationClassification and diagnostic criteria for psoriatic arthritis
Helliwell, P., & Taylor, W. J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032318 · Cited by 290
Cited by
Cargill, M., Schrodi, S. J., Chang, M., Garcia, V. E., Brandon, R., Callis, K. P., Matsunami, N., Ardlie, K. G., Civello, D., Catanese, J. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511051 · Cited by 1,086
Greb, J. E., Goldminz, A. M., Elder, J. T., Lebwohl, M. G., Gladman, D. D., Wu, J. J., Mehta, N. N., Finlay, A. Y., & Gottlieb, A. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.82 · Cited by 922
Self-citationMcInnes, I. B., Mease, P. J., Kirkham, B., Kavanaugh, A., Ritchlin, C. T., Rahman, P., van der Heijde, D., Landewé, R., Conaghan, P. G., Gottlieb, A. B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61134-5 · Cited by 858
Self-citationMcInnes, I. B., Kavanaugh, A., Gottlieb, A. B., Puig, L., Rahman, P., Ritchlin, C., Brodmerkel, C., Li, S., Wang, Y., Mendelsohn, A. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60594-2 · Cited by 807
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Mease, P. J., McInnes, I. B., Kirkham, B., Kavanaugh, A., Rahman, P., van der Heijde, D., Landewé, R., Nash, P., Pricop, L., Yuan, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412679 · Cited by 746
Self-citationRitchlin, C., Rahman, P., Kavanaugh, A., McInnes, I. B., Puig, L., Li, S., Wang, Y., Shen, Y.-K., Doyle, M. K., Mendelsohn, A. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204655 · Cited by 662
Wilson, F. C., Icen, M., Crowson, C. S., McEvoy, M. T., Gabriel, S. E., & Kremers, H. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24172 · Cited by 605
Mease, P. J., van der Heijde, D., Ritchlin, C. T., Okada, M., Cuchacovich, R. S., Shuler, C. L., Lin, C.-Y., Braun, D. K., Lee, C. H., & Gladman, D. D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209709 · Cited by 580
Self-citationTofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
Mease, P., Hall, S., FitzGerald, O., van der Heijde, D., Merola, J. F., Avila-Zapata, F., Cieślak, D., Graham, D., Wang, C., Menon, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615975 · Cited by 571
Self-citationLebwohl, M. G., Bachelez, H., Barker, J., Girolomoni, G., Kavanaugh, A., Langley, R. G., Paul, C. F., Puig, L., Reich, K., & van de Kerkhof, P. C. M. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.12.018 · Cited by 515
Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis
Chandran, V., & Raychaudhuri, S. P. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.12.001 · Cited by 510
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
Gladman, D., Rigby, W., Azevedo, V. F., Behrens, F., Blanco, R., Kaszuba, A., Kudlacz, E., Wang, C., Menon, S., Hendrikx, T., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615977 · Cited by 510
Self-citationMease, P. J., Gladman, D. D., Papp, K. A., Khraishi, M. M., Thaçi, D., Behrens, F., Northington, R., Fuiman, J., Bananis, E., Boggs, R., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.07.023 · Cited by 508
Self-citationCoates, L. C., Moverley, A. R., McParland, L., Brown, S., Navarro-Coy, N., O'Dwyer, J. L., Meads, D. M., Emery, P., Conaghan, P. G., & Helliwell, P. S. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00347-5 · Cited by 476
Perera, G. K., Di Meglio, P., & Nestle, F. O. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132448 · Cited by 462
Smolen, J. S., Braun, J., Dougados, M., Emery, P., FitzGerald, O., Helliwell, P., Kavanaugh, A., Kvien, T. K., Landewé, R., Luger, T., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203419 · Cited by 447
Self-citationThe IL-23-IL-17 axis in inflammatory arthritis
Lubberts, E. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.53 · Cited by 442
Krishnan, Y., & Grodzinsky, A. J. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.05.005 · Cited by 443
Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
Schafer, P. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.001 · Cited by 439
Nash, P., Kirkham, B., Okada, M., Rahman, P., Combe, B., Burmester, G.-R., Adams, D. H., Kerr, L., Lee, C., Shuler, C. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31429-0 · Cited by 405
Self-citationBrodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Mease, P. J., Genovese, M. C., Greenwald, M. W., Ritchlin, C. T., Beaulieu, A. D., Deodhar, A., Newmark, R., Feng, J., Erondu, N., & Nirula, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315231 · Cited by 395
Self-citationPreventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition
Scher, J. U., Ogdie, A., Merola, J. F., & Ritchlin, C. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0175-0 · Cited by 394
Tsoi, L. C., Stuart, P. E., Tian, C., Gudjonsson, J. E., Das, S., Zawistowski, M., Ellinghaus, E., Barker, J. N., Chandran, V., Dand, N., et al. (2017) · Nature Communications · doi:10.1038/ncomms15382 · Cited by 384
Self-citationPsoriasis: classical and emerging comorbidities
Oliveira, M. D. F. S. P. D., Rocha, B. D. O., & Duarte, G. V. (2015) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20153038 · Cited by 374
Vincent, F. B., Morand, E. F., Murphy, K., Mackay, F., Mariette, X., & Marcelli, C. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202545 · Cited by 356
McInnes, I. B., Sieper, J., Braun, J., Emery, P., van der Heijde, D., Isaacs, J. D., Dahmen, G., Wollenhaupt, J., Schulze-Koops, H., Kogan, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202646 · Cited by 343
Eder, L., Haddad, A., Rosen, C. F., Lee, K., Chandran, V., Cook, R., & Gladman, D. D. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39494 · Cited by 328
Self-citationDi Meglio, P., Villanova, F., & Nestle, F. O. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015354 · Cited by 317
Gisondi, P., Tinazzi, I., El-Dalati, G., Gallo, M., Biasi, D., Barbara, L. M., & Girolomoni, G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.075101 · Cited by 304
Mease, P., van der Heijde, D., Landewé, R., Mpofu, S., Rahman, P., Tahir, H., Singhal, A., Boettcher, E., Navarra, S., Meiser, K., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212687 · Cited by 303
Self-citationPsoriasis induced by anti–tumor necrosis factor therapy: A paradoxical adverse reaction
Sfikakis, P. P., Iliopoulos, A., Elezoglou, A., Kittas, C., & Stratigos, A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21233 · Cited by 301
Kavanaugh, A., Ritchlin, C., Rahman, P., Puig, L., Gottlieb, A. B., Li, S., Wang, Y., Noonan, L., Brodmerkel, C., Song, M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204741 · Cited by 295
Edwards, C. J., Blanco, F. J., Crowley, J., Birbara, C. A., Jaworski, J., Aelion, J., Stevens, R. M., Vessey, A., Zhan, X., & Bird, P. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207963 · Cited by 287
Jensen, P., & Skov, L. (2016) · Dermatology · doi:10.1159/000455840 · Cited by 278
Mease, P. J., & Armstrong, A. W. (2014) · Drugs · doi:10.1007/s40265-014-0191-y · Cited by 271
Self-citationTam, L.-S., Tomlinson, B., Chu, T. T.-W., Li, M., Leung, Y.-Y., Kwok, L.-W., Li, T. K., Yu, T., Zhu, Y.-E., Wong, K.-C., et al. (2008) · Rheumatology · doi:10.1093/rheumatology/ken090 · Cited by 257
Fujita, H., Terui, T., Hayama, K., Akiyama, M., Ikeda, S., Mabuchi, T., Ozawa, A., Kanekura, T., Kurosawa, M., Komine, M., et al. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14523 · Cited by 254
EL-GABALAWY, H., GUENTHER, L. C., & BERNSTEIN, C. N. (2010) · The Journal of Rheumatology Supplement · doi:10.3899/jrheum.091461 · Cited by 253
Mease, P., Coates, L. C., Helliwell, P. S., Stanislavchuk, M., Rychlewska-Hanczewska, A., Dudek, A., Abi-Saab, W., Tasset, C., Meuleners, L., Harrison, P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32483-8 · Cited by 196
Self-citationThe gut microbiome in psoriasis and psoriatic arthritis
Myers, B., Brownstone, N., Reddy, V., Chan, S., Thibodeaux, Q., Truong, A., Bhutani, T., Chang, H.-W., & Liao, W. (2019) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101494 · Cited by 127
Kimball, A. B., Leonardi, C., Stahle, M., Gulliver, W., Chevrier, M., Fakharzadeh, S., Goyal, K., Calabro, S., Langholff, W., Menter, A., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13013 · Cited by 117
Chimenti, M. S., Sunzini, F., Fiorucci, L., Botti, E., Fonti, G. L., Conigliaro, P., Triggianese, P., Costa, L., Caso, F., Giunta, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02363 · Cited by 77
Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis
Chandran, V., Abji, F., Perruccio, A. V., Gandhi, R., Li, S., Cook, R. J., & Gladman, D. D. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214737 · Cited by 48
Self-citationSozzani, S., Abbracchio, M. P., Annese, V., Danese, S., De Pità, O., De Sarro, G., Maione, S., Olivieri, I., Parodi, A., & Sarzi-Puttini, P. (2014) · Autoimmunity · doi:10.3109/08916934.2014.897333 · Cited by 22
Waszczykowski, M., Fabiś-Strobin, A., Bednarski, I., Lesiak, A., Narbutt, J., & Fabiś, J. (2020) · Diagnostics · doi:10.3390/diagnostics11010052 · Cited by 9
Metadata
- Authors
- Gladman, D. D., Antoni, C., Mease, P., Clegg, D. O., & Nash, P.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 64
- Pages
- ii14-ii17
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2139788459
- Cited by
- 1,536
- References
- 25
- FWCI
- 19.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.